Welcoming Gentuity® to the Nipro Vascular Portfolio
CONTINUING TO RAISE THE BAR FOR VASCULAR
Nipro Medical Corporation is proud to announce a commercial partnership in the United States with Gentuity LLC.
Gentuity, an imaging technology firm founded in Massachusetts in 2015, is dedicated to developing next-generation intravascular devices that capitalize on today’s best-in-class technologies. With a proprietary platform fully incorporating the company’s AI tools to enhance ease of use and procedural success, Gentuity is transforming the world of intravascular imaging.
Together with Gentuity, Nipro is excited to continue advancing patient care, improving outcomes, and delivering more value to healthcare providers.
EXPERIENCE THE NEXT GENERATION OF OCT
Nipro is excited to now offer the following Gentuity products:
- High-Frequency OCT Imaging System: An innovative and ergonomic console powered by machine learning technology, this system offers excellent planning insights with One Second Imaging™ – the fastest and longest pullback available in the U.S.
- Vis-Rx® Micro-Imaging Catheter: Presenting the world’s smallest imaging catheter at 1.8F with a crossing profile less than half the size of other intravascular imaging catheters, interventional cardiologists can achieve total vessel imaging pre- and post-procedure with ease and confidence.
The Vis-Rx® Micro-Imaging Catheter operates exclusively on the Gentuity HF-OCT Imaging System.
YOUR LINK BETWEEN INNOVATION AND CARE
In April, Nipro announced the creation of our U.S. vascular division, followed by the launch of four products in September. Today, we are delighted to welcome Gentuity’s portfolio to our cath lab offering – further illustrating Nipro’s commitment to bringing innovative vascular and cardiovascular products to market, designed with patients and healthcare professionals in mind.
This addition offers not one, but TWO imaging systems for complete coverage of NIRS-IVUS and HF-OCT as Nipro continues to build its portfolio to address interventional cardiology procedures and to satisfy unmet needs (i.e. coronary artery disease, vulnerable plaque, etc.).